AFYA Quote, Financials, Valuation and Earnings

BRF SA has a net margin of 14.26% compared to Afya's net margin of 6.6%. Afya's return on equity of 15.17% beat BRF SA's return on equity of 20.01%.

Afya has a consensus price target of $19.72, signalling upside risk potential of 25.3%. On the other hand BRF SA has an analysts' consensus of $5.04 which suggests that it could grow by 34.33%. Given that BRF SA has higher upside potential than Afya, analysts believe BRF SA is more attractive than Afya.

Afya has a beta of 0.894, which suggesting that the stock is 10.643% less volatile than S&P 500. In comparison BRF SA has a beta of 1.886, suggesting its more volatile than the S&P 500 by 88.586%.

Afya has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. BRF SA offers a yield of 3.12% to investors and pays a quarterly dividend of $0.02 per share. Afya pays -- of its earnings as a dividend. BRF SA pays out -- of its earnings as a dividend.

Afya quarterly revenues are $151.6M, which are smaller than BRF SA quarterly revenues of $2.8B. Afya's net income of $21.6M is lower than BRF SA's net income of $184.6M. Notably, Afya's price-to-earnings ratio is 12.71x while BRF SA's PE ratio is 8.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya is 2.36x versus 0.56x for BRF SA. Usually stocks with elevated PS ratios are considered overvalued.

Brasilagro - Cia Bras de Prop Agricolas has a net margin of 14.26% compared to Afya's net margin of 21.53%. Afya's return on equity of 15.17% beat Brasilagro - Cia Bras de Prop Agricolas's return on equity of 13.33%.

Afya has a consensus price target of $19.72, signalling upside risk potential of 25.3%. On the other hand Brasilagro - Cia Bras de Prop Agricolas has an analysts' consensus of -- which suggests that it could fall by --. Given that Afya has higher upside potential than Brasilagro - Cia Bras de Prop Agricolas, analysts believe Afya is more attractive than Brasilagro - Cia Bras de Prop Agricolas.

Afya has a beta of 0.894, which suggesting that the stock is 10.643% less volatile than S&P 500. In comparison Brasilagro - Cia Bras de Prop Agricolas has a beta of 0.822, suggesting its less volatile than the S&P 500 by 17.786%.

Afya has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Brasilagro - Cia Bras de Prop Agricolas offers a yield of 7.38% to investors and pays a quarterly dividend of $0.28 per share. Afya pays -- of its earnings as a dividend. Brasilagro - Cia Bras de Prop Agricolas pays out 140.63% of its earnings as a dividend.

Afya quarterly revenues are $151.6M, which are larger than Brasilagro - Cia Bras de Prop Agricolas quarterly revenues of $81.6M. Afya's net income of $21.6M is higher than Brasilagro - Cia Bras de Prop Agricolas's net income of $17.6M. Notably, Afya's price-to-earnings ratio is 12.71x while Brasilagro - Cia Bras de Prop Agricolas's PE ratio is 6.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya is 2.36x versus 1.67x for Brasilagro - Cia Bras de Prop Agricolas. Usually stocks with elevated PS ratios are considered overvalued.

Minerva SA has a net margin of 14.26% compared to Afya's net margin of 1.01%. Afya's return on equity of 15.17% beat Minerva SA's return on equity of -1.34%.

Afya has a consensus price target of $19.72, signalling upside risk potential of 25.3%. On the other hand Minerva SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Afya has higher upside potential than Minerva SA, analysts believe Afya is more attractive than Minerva SA.

Afya has a beta of 0.894, which suggesting that the stock is 10.643% less volatile than S&P 500. In comparison Minerva SA has a beta of -0.273, suggesting its less volatile than the S&P 500 by 127.29%.

Afya has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Minerva SA offers a yield of 0% to investors and pays a quarterly dividend of $0.16 per share. Afya pays -- of its earnings as a dividend. Minerva SA pays out 70.14% of its earnings as a dividend. Minerva SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Afya quarterly revenues are $151.6M, which are smaller than Minerva SA quarterly revenues of $1.5B. Afya's net income of $21.6M is higher than Minerva SA's net income of $15.5M. Notably, Afya's price-to-earnings ratio is 12.71x while Minerva SA's PE ratio is 57.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya is 2.36x versus 0.09x for Minerva SA. Usually stocks with elevated PS ratios are considered overvalued.

Vasta Platform has a net margin of 14.26% compared to Afya's net margin of -35.03%. Afya's return on equity of 15.17% beat Vasta Platform's return on equity of -1.15%.

Afya has a consensus price target of $19.72, signalling upside risk potential of 25.3%. On the other hand Vasta Platform has an analysts' consensus of -- which suggests that it could grow by 7.63%. Given that Afya has higher upside potential than Vasta Platform, analysts believe Afya is more attractive than Vasta Platform.

Afya has a beta of 0.894, which suggesting that the stock is 10.643% less volatile than S&P 500. In comparison Vasta Platform has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Afya has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Vasta Platform offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Afya pays -- of its earnings as a dividend. Vasta Platform pays out -- of its earnings as a dividend.

Afya quarterly revenues are $151.6M, which are larger than Vasta Platform quarterly revenues of $39.7M. Afya's net income of $21.6M is higher than Vasta Platform's net income of -$13.9M. Notably, Afya's price-to-earnings ratio is 12.71x while Vasta Platform's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya is 2.36x versus 0.65x for Vasta Platform. Usually stocks with elevated PS ratios are considered overvalued.